SynthesisFrontiers in oncology2022

Systematic Review of Olaparib in the Treatment of Recurrent Platinum Sensitive Ovarian Cancer.

Qian Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.